Cargando…

Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS

Candesartan and olmesartan are angiotensin II receptor blockers (ARBs) used for the treatment of hypertension and heart failure. Quantitation methods for candesartan and olmesartan were developed using ultra-high performance liquid chromatography-tandem mass spectrometry following protein precipitat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Hyeon-Cheol, Seo, Yo-Han, Gu, Namyi, Rhee, Moo Yong, Shin, Kwang-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718358/ https://www.ncbi.nlm.nih.gov/pubmed/35024363 http://dx.doi.org/10.12793/tcp.2021.29.e21

Ejemplares similares

Development of a UPLC-MS/MS method for the therapeutic monitoring of L-asparaginase
por: Jeong, Hyeon-Cheol, et al.
Publicado: (2018)

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLC–MS/MS and its application in bioequivalence studies
por: Singh, Bhupinder, et al.
Publicado: (2014)

Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS)
por: Wei, Zhuodu, et al.
Publicado: (2022)

Validated UPLC-MS/MS method for the determination of tadalafil in human plasma and its application to a pharmacokinetic study
por: Kim, Kwang-Youl, et al.
Publicado: (2017)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma
por: Alam, Mohd Aftab, et al.
Publicado: (2018)

Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic study
por: Kumari Karra, Vijaya, et al.
Publicado: (2012)

Pharmacokinetic and Metabolism Studies of Curculigoside C by UPLC-MS/MS and UPLC-QTOF-MS
por: Wu, Di, et al.
Publicado: (2018)

Erratum to “Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma”
por: Alam, Mohd Aftab, et al.
Publicado: (2019)

UPLC-MS/MS Determination of Linezolid and Heme in Plasma of Infected Patients and Correlation Analysis
por: Wang, Yingying, et al.
Publicado: (2021)

Determination of Tropifexor in Beagle Dog Plasma by UPLC-MS/MS and Its Application in Pharmacokinetics
por: Su, Yan-Ding, et al.
Publicado: (2022)

A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma
por: Li, Xia, et al.
Publicado: (2023)

Accurate Determination of the Degree of Deacetylation of Chitosan Using UPLC–MS/MS
por: Xue, Ting, et al.
Publicado: (2022)

Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2017)

Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC–MS/MS()
por: Gudlawar, Shiva Kumar, et al.
Publicado: (2017)

Determination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study()
por: Chaudhary, Darshan V., et al.
Publicado: (2016)

Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies
por: Chen, Mengchun, et al.
Publicado: (2020)

Simultaneous determination of five essential amino acids in plasma of Hyperlipidemic subjects by UPLC-MS/MS
por: Chen, Zhibin, et al.
Publicado: (2020)

Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS
por: Li, Ying, et al.
Publicado: (2022)

Pharmacokinetic Analysis of Diosgenin in Rat Plasma by a UPLC-MS/MS Approach
por: Liu, Pei, et al.
Publicado: (2022)

In Vivo Metabolism Study of Xiamenmycin A in Mouse Plasma by UPLC-QTOF-MS and LC-MS/MS
por: Lei, Feng, et al.
Publicado: (2015)

A validated UPLC–MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma
por: Zeng, Jing, et al.
Publicado: (2017)

New UPLC–MS/MS assay for the determination of tamoxifen and its metabolites in human plasma, application to patients
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2019)

Development and Validation of UPLC-MS/MS Method for Determination of Enasidenib in Rat Plasma and Its Pharmacokinetic Application
por: Li, Shuang-long, et al.
Publicado: (2020)

Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
por: He, Yan, et al.
Publicado: (2022)

Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics
por: Liu, Ya-nan, et al.
Publicado: (2022)

Determination of Tenacissoside G, Tenacissoside H, and Tenacissoside I in Rat Plasma by UPLC-MS/MS and Their Pharmacokinetics
por: Chen, Fan, et al.
Publicado: (2023)

Pharmacokinetic and Metabolism Studies of 12-Riboside-Pseudoginsengenin DQ by UPLC-MS/MS and UPLC-QTOF-MS(E)
por: Wang, Zhenzhou, et al.
Publicado: (2018)

An Efficient UPLC-MS/MS Method Established to Detect Relugolix Concentration in Rat Plasma
por: Xing, Liying, et al.
Publicado: (2022)

UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma
por: Li, Qingqing, et al.
Publicado: (2022)

Establishment of a sensitive UPLC-MS/MS method to quantify safinamide in rat plasma
por: Wang, Ying, et al.
Publicado: (2023)

Pharmacokinetics of Dibutyl Phthalate (DBP) in the Rat Determined by UPLC-MS/MS
por: Chang, Li-Wen, et al.
Publicado: (2013)

Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol
por: Gervasoni, Jacopo, et al.
Publicado: (2018)

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study
por: Nishida, Yayoi, et al.
Publicado: (2011)

Pharmacokinetics and metabolism of icaritin in rats by UPLC‐MS/MS
por: Huang, Zhen‐Wu, et al.
Publicado: (2019)

Development and Validation of a UPLC-MS/MS and UPLC-HR-MS Method for the Determination of Fumonisin B1 and Its Hydrolysed Metabolites and Fumonisin B2 in Broiler Chicken Plasma
por: De Baere, Siegrid, et al.
Publicado: (2018)

A high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma
por: Gu, Er-Min, et al.
Publicado: (2022)

Publisher Correction: Determination of total and unbound docetaxel in plasma by ultrafiltration and UPLC-MS/MS: application to pharmacokinetic studies
por: Sheu, Ming-Thau, et al.
Publicado: (2018)

Determination and pharmacokinetic analysis of ticarcillin disodium–clavulanate potassium for injection in rat plasma by UPLC-ESI-MS/MS
por: Wang, Moli, et al.
Publicado: (2020)

Development and Validation of a UPLC-MS/MS Method for the Quantitative Determination and Pharmacokinetic Analysis of Cirsimarin in Rat Plasma
por: Zhang, En, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afpr94li26j9i56o6uj310aqb7